Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v18-EN
Language French English
Date Updated 2024-01-02 2024-01-02
Drug Identification Number 02420333 02420333
Brand name AA-ADEFOVIR AA-ADEFOVIR
Common or Proper name APO-ADEFOVIR DIPIVOXIL APO-ADEFOVIR DIPIVOXIL
Company Name AA PHARMA INC AA PHARMA INC
Ingredients ADEFOVIR DIPIVOXIL ADEFOVIR DIPIVOXIL
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 BTL 30 BTL
ATC code J05AF J05AF
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-06-30 2022-06-30
Actual start date 2022-06-30 2022-06-30
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments